NCT01445561View on ClinicalTrials.gov

Ultra Low Dose Interleukin-2 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 28, 2011

Primary Completion Date

July 15, 2013

Study Completion Date

July 15, 2013

Conditions
Hematologic Diseases
Interventions
DRUG

Interleukin-2 (100,00 IU/m(2) SQ)

100,000 International Units/m2 SQ daily for 5 days

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT01445561 - Ultra Low Dose Interleukin-2 in Healthy Volunteers | Biotech Hunter | Biotech Hunter